Table 2 Variant details and tumor mutational burden.

From: Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features

Case

TMB

SNVs and structural variants

1m1

9.9

FH (p.A393_V394del)

1m2

8.4

FH (p.A393_V394del)

1m3

7.6

FH (p.A393_V394del)

1m4

8.4

FH (p.A393_V394del)

2

3.0

FH (p.R233H)

3

3.0

FH donor splice site mutation

  

TP53 p.C275S

  

TP53 splice site mutation

4

8.4

FH (p.E432Kfs*17)

  

BRAF (p.G469V)

5

6.1

CTNNB1 (p.D32N)

  

NF1 (p.S361I)

6m1

3.0

CTNNB1 (p.A43_P52del)

6m2

3.0

CTNNB1 (p.A43_P52del)

7

3.8

CTNNB1 (p.D32V)

8

3.0

CTNNB1 (p.H36_T42delinsP)

9

3.8

APC (p.R1386_V1390del)

10

6.1

NF2 c.1122+1G>T ()

  

CHEK2 (p.I157T)

11

3.0

MBD4 c.1562-1G>T

  

AC096669.2 intron 2 -ARID1 B intron 4 rearrangement

12a

*

None

13

11.4

None

14

3.8

None

15

4.6

None

16b

Low DNA/fail

N/A

17b

Low DNA/fail

N/A

18b

Low DNA/fail

N/A

19

6.1

CTNNB1 (p.S37A)

20

3.0

CTNNB1 (p.T41A)

21

7.6

CTNNB1 (p.I35S)

22

3.8

CTNNB1 (p.G34R)

23

3.0

None

24

5.3

None

25

3.0

None

26

3.8

None

  1. Cases with metastases (m) are listed in chronologic order. SNVs listed here include those not recurrently seen in the series. *The TMB cannot be accurately determined in this case given the borderline QC metrics.
  2. TMB tumor mutational burden (per megabase), SNVs single nucleotide variants.
  3. aAverage number of reads = 49 (borderline QC metrics).
  4. bFailed next-generation sequencing or low DNA content.